ISB News

Awards: Claudia Ludwig Receives AWIS Award

Photo above: ISB’s Claudia Ludwig, MEd (center); Emily Fox, MEng, EE, PhD, for outstanding scientific advancement in STEM (left); Alyssa Taylor, PhD, for excellence in science education (right). Credit: courtesy of AWIS and photographer Martina Machackova

Congratulations to Claudia Ludwig, Director of Systems Education Experiences (SEE), on receiving an award from the Seattle chapter of the Association for Women in Science for Excellence in Science Outreach. The ceremony to honor award winners took place on June 6.

Learn more about Claudia’s work at: see.isbscience.net

Watch this video about SEE, which was featured in the National Science Foundation’s 2017  STEM for All Video Showcase: stemforall2017.videohall.com/presentations/1014

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.